会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • System for providing an open airway and methods of use thereof
    • 用于提供开放气道的系统及其使用方法
    • US20090107509A1
    • 2009-04-30
    • US11980855
    • 2007-10-31
    • Joseph A. Sniadach
    • Joseph A. Sniadach
    • A61M16/04
    • A61M16/0488A61M2202/06A61M2202/0014
    • In a system for dislodging a foreign body 60 from the vocal cords 52 of a patient 32, a retrograde intubation tube 64 is passed through the cricoidthyroid membrane 58, and between the vocal cords and the foreign body, and out of the oral cavity opening 34. A guide wire 84 is passed through, and extends outward from opposite ends 68 and 70 of, the tube 64. The carrier device 88, having a foreign-body dislodging means 104, is formed with a hollow opening 93, and is moved over, and guided by, the guidewire 84 and the tube 64 to a location adjacent the foreign body 60. The tube 64 and the guidewire 84 are removed, and the dislodging means 104 is manipulated to dislodge, and facilitate removal of, the foreign body 60.
    • 在从患者32的声带52移除异物60的系统中,逆行插管64穿过双锥体膜58,并且在声带与异物之间,并且从口腔开口34 引导线84从管64的相对端68和70穿过并向外延伸。具有异物移动装置104的载体装置88形成有中空开口93,并且移动 并且由导丝84和管64引导到与异物60相邻的位置。管64和导丝84被移除,并且操纵移除装置104以移除并促进异物60 。
    • 4. 发明授权
    • Intubation system and methods of use thereof
    • 插管系统及其使用方法
    • US06718970B2
    • 2004-04-13
    • US09912699
    • 2001-07-25
    • Joseph A. Sniadach
    • Joseph A. Sniadach
    • A61M1600
    • A61M16/0488A61M16/0409A61M16/0418A61M16/0429A61M2209/06
    • An intubation system for intubating a patient includes an esophageal obturator 10, an intubation slide 30, a directing guide wire assembly 48 and an airway tube 60. In a method for obtaining an unobstructed airway into the patient's lungs, the esophageal obturator 10 is used to occlude the patient's esophagus F. The intubation slide 30 is inserted into the patient's mouth C and provides a guide for a directing guide wire 50 of the assembly 48 to locate a distal end 59 of the wire in the patient's trachea E. A distal end of the airway tube 60, which surrounds, or may be slipped over, the emplaced assembly 48, is also thereby located in the patient's trachea E. The obturator 10, the slide 30 and the assembly 48 are removed, thereby leaving the airway tube 60 in place to provide ventilation for the patient.
    • 用于插管患者的插管系统包括食管闭塞器10,插管滑动件30,引导导丝组件48和气道管60.在获得患者肺部无阻碍气道的方法中,使用食管闭孔器10 阻塞患者的食管F.将插管滑块30插入病人的口腔C中,并提供用于组件48的引导导丝50的引导件,以将线的远端59定位在病人的气管E中。远端 围绕放置的组件48也包围或可能滑过的气道管60也由此位于患者的气管E中。取出填塞器10,滑动件30和组件48,从而使气道管60离开 为病人提供通气的地方。
    • 5. 发明申请
    • Coded medications and methods of preparing same for identification and distinguishment
    • 编码药物及其制备方法用于鉴别和鉴别
    • US20090226378A1
    • 2009-09-10
    • US12454439
    • 2009-05-18
    • Joseph A. Sniadach
    • Joseph A. Sniadach
    • A61K49/00
    • A61J1/2093A61J1/202A61J2205/20
    • A selected substance is dissolved into a given injectable fluid medication having an initial clear visual appearance. The selected substance is selected from a group of substances which, when dissolved in the injectable fluid medication, will alter the clear appearance to produce a non-clear or altered visual appearance. The altered visual appearance could be a color, which, by code, identifies the given injectable fluid medication, and distinguishes the given injectable fluid medication from a different injectable fluid medication, the clear visual appearance of which has been altered by dissolving another selected substance to produce a colored visual appearance different from the color of the altered visual appearance of the given injectable fluid medication.
    • 将选定的物质溶解在具有初始清晰视觉外观的给定的可注射液体药物中。 所选择的物质选自一组物质,当溶解在可注射液体药物中时,将改变清晰的外观以产生不透明或改变的视觉外观。 改变的视觉外观可以是一种颜色,其通过代码识别给定的可注射液体药物,并且将给定的可注射液体药物与不同的可注射液体药物区分开,其可视化外观通过将另一种选择的物质溶解 产生不同于给定注射液药物改变的视觉外观的颜色的彩色视觉外观。
    • 6. 发明申请
    • Airway device and methods of making and use thereof
    • 气道装置及其制造和使用方法
    • US20090211574A1
    • 2009-08-27
    • US12074736
    • 2008-03-06
    • Joseph A. Sniadach
    • Joseph A. Sniadach
    • A61M16/04A62B18/02
    • A61M16/0488A61M16/0459A61M16/06A61M16/0816
    • An airway device 64 includes a hollow tube 51 having a proximal end 65b and a distal end 71, and is formed with a straight section 65 and a curved section 68. The tube 51 can include a proximal portion 65a, which extends from the proximal end 65b for receipt of a face mask 180. When the airway device 64 is placed in a patient's mouth 28, oral cavity 34 and oropharyngeal area 36, the distal end 71 is located at the patient's glottic opening 46 and vocal cords 40. Inflatable cuffs 75, 73 and 73a may be located individually on the tube 51 in selectable single, double and triple cuff embodiments to form seals in the areas of the patient's mouth 28, oral cavity 34, oropharyngeal area 36, glottic opening 46 and vocal cords 40, esophageal opening 48 and inner nasal-passage opening 33.
    • 气道装置64包括具有近端65b和远端71的中空管51,并且形成有直部65和弯曲部68.管51可包括近端部分65a,该近端部分65a从近端 65b用于接收面罩180.当气道装置64放置在病人口28,口腔34和口咽区域36中时,远端71位于病人的声门开口46和声带40.充气袖口75 ,73和73a可以以可选择的单,双和三箍实施例分别位于管51上,以在患者口28,口腔34,口咽区域36,声门开口46和声带40的区域中形成密封,食管 开口48和内鼻通道开口33。
    • 7. 发明申请
    • Coded medication and methods of preparing same for identification and distinguishment
    • 编码药物及其制备方法进行鉴定和鉴别
    • US20090191132A1
    • 2009-07-30
    • US12322021
    • 2009-01-28
    • Joseph A. Sniadach
    • Joseph A. Sniadach
    • A61K31/495A61J1/14
    • A61J1/2093A61J1/10A61J2205/20A61K9/0019
    • A selected substance is dissolved into a given injectable fluid medication having an initial clear visual appearance. The selected substance is selected from a group of substances which, when dissolved in the injectable fluid medication, will alter the clear appearance to produce a non-clear or altered visual appearance. The altered visual appearance could be a color, which, by code, identifies the given injectable fluid medication, and distinguishes the given injectable fluid medication from a different injectable fluid medication, the clear visual appearance of which has been altered by dissolving another selected substance to produce a colored visual appearance different from the color of the altered visual appearance of the given injectable fluid medication.
    • 将选定的物质溶解在具有初始清晰视觉外观的给定的可注射液体药物中。 所选择的物质选自一组物质,当溶解在可注射液体药物中时,将改变清晰的外观以产生不透明或改变的视觉外观。 改变的视觉外观可以是一种颜色,其通过代码识别给定的可注射液体药物,并且将给定的可注射液体药物与不同的可注射液体药物区分开,其可视化外观通过将另一种选择的物质溶解 产生不同于给定注射液药物改变的视觉外观的颜色的彩色视觉外观。